Stocktoria
aTYR PHARMA INC ATYR
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2015-05-07
aTYR PHARMA INC insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| SCHIMMEL PAUL | director | 2026-05-27 | Buy | 100,000 | $0.50 |
| Broadfoot Jill Marie | Chief Financial Officer | 2026-02-04 | Sell | 1,558 | $0.98 |
| Shukla Sanjay | President and CEO | 2026-02-04 | Sell | 3,745 | $0.98 |
| DENYES NANCY | General Counsel | 2026-02-04 | Sell | 1,118 | $0.98 |
| Broadfoot Jill Marie | Chief Financial Officer | 2026-02-03 | Option exercise | 3,750 | — |
| Shukla Sanjay | President and CEO | 2026-02-03 | Option exercise | 10,375 | — |
| DENYES NANCY | General Counsel | 2026-02-03 | Option exercise | 2,687 | — |
Source: SEC EDGAR filings · CIK 0001339970 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.